ATOSSA THERAPEUTICS, INC. Total Assets

Quick Answer

ATOSSA THERAPEUTICS, INC. reported Total Assets of $47.61 million for the year ending 2025.

  • ATOSSA THERAPEUTICS, INC. showed a decrease of -37.7% in Total Assets from 2024 to 2025.
  • This data is from ATOSSA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: $8.91 million | Q2 2013: $10.06 million | Q3 2013: $13.48 million | Q1 2014: $22.38 million | Q2 2014: $19.82 million | Q3 2014: $16.77 million | Q1 2015: $13.80 million | Q2 2015: $16.56 million | Q3 2015: $12.36 million | Q1 2016: $5.10 million | Q2 2016: $3.28 million | Q3 2016: $6.28 million | Q1 2017: $2.30 million | Q2 2017: $4.71 million | Q3 2017: $3.63 million | Q1 2018: $5.98 million | Q2 2018: $16.58 million | Q3 2018: $14.12 million | Q1 2019: $21.02 million | Q2 2019: $18.61 million | Q3 2019: $16.60 million | Q1 2020: $11.81 million | Q2 2020: $10.21 million | Q3 2020: $11.44 million | Q1 2021: $141.08 million | Q2 2021: $145.87 million | Q3 2021: $143.02 million | Q1 2022: $137.48 million | Q2 2022: $134.05 million | Q3 2022: $126.72 million | Q1 2023: $116.20 million | Q2 2023: $108.36 million | Q3 2023: $101.70 million | Q1 2024: $91.09 million | Q2 2024: $85.86 million | Q3 2024: $79.48 million | Q1 2025: $70.75 million | Q2 2025: $64.52 million | Q3 2025: $58.01 million.
  • Over the full 15 years of available data (2011 to 2025), ATOSSA THERAPEUTICS, INC.'s Total Assets has grown by 1,449.8%.
  • Historical annual values: Fiscal year 2025: $47.61 million | Fiscal year 2024: $76.44 million | Fiscal year 2023: $96.25 million | Fiscal year 2022: $123.53 million | Fiscal year 2021: $141.26 million | Fiscal year 2020: $42.84 million | Fiscal year 2019: $14.49 million | Fiscal year 2018: $11.72 million | Fiscal year 2017: $8.16 million | Fiscal year 2016: $4.14 million | Fiscal year 2015: $6.24 million | Fiscal year 2014: $11.76 million | Fiscal year 2013: $12.01 million | Fiscal year 2012: $6.83 million | Fiscal year 2011: $3.07 million.
  • Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: